J. Hare – Comparison of Allogen vs Autolog Mesenchymal Stem Cells in Pts. with Ischemic CMP – Video

Posted: Published on November 7th, 2012

This post was added by Dr. Richardson




J. Hare - Comparison of Allogen vs Autolog Mesenchymal Stem Cells in Pts. with Ischemic CMP
J. Hare - Randomized Comparison of Allogeneic vs Autologous Mesenchymal Stem Cells in Patients with Ischemic Cardiomyopathy POSEIDON - This trial was designed to test the safety and efficacy of allogeneic vs. autologous mesenchymal stem cells in patients with ischemic cardiomyopathy. Annual Session of the American Heart Association November 5, 2012, Los AngelesFrom:CardioletterViews:0 0ratingsTime:08:37More inScience Technology

Read this article:
J. Hare - Comparison of Allogen vs Autolog Mesenchymal Stem Cells in Pts. with Ischemic CMP - Video

Related Posts
This entry was posted in Mesenchymal Stem Cells. Bookmark the permalink.

Comments are closed.